NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 283 filers reported holding NEOGENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,413,922 | +554.6% | 114,953 | +1717.2% | 0.00% | – |
| Q4 2021 | $216,000 | -41.0% | 6,326 | -16.6% | 0.00% | -100.0% |
| Q3 2021 | $366,000 | -39.0% | 7,587 | -43.0% | 0.00% | -50.0% |
| Q2 2021 | $600,000 | -14.8% | 13,300 | -8.9% | 0.00% | -33.3% |
| Q1 2021 | $704,000 | -59.1% | 14,600 | -54.4% | 0.00% | -57.1% |
| Q4 2020 | $1,722,000 | +255.8% | 32,000 | +144.3% | 0.01% | +250.0% |
| Q3 2020 | $484,000 | +34.4% | 13,100 | +12.9% | 0.00% | 0.0% |
| Q2 2020 | $360,000 | -13.7% | 11,600 | -23.2% | 0.00% | -33.3% |
| Q1 2020 | $417,000 | +87.0% | 15,100 | +29.7% | 0.00% | +50.0% |
| Q3 2019 | $223,000 | -63.3% | 11,640 | -58.0% | 0.00% | -60.0% |
| Q2 2019 | $607,000 | +983.9% | 27,700 | +307.4% | 0.01% | – |
| Q3 2016 | $56,000 | -43.4% | 6,800 | -44.7% | 0.00% | -100.0% |
| Q2 2016 | $99,000 | +3200.0% | 12,300 | +2360.0% | 0.00% | – |
| Q1 2016 | $3,000 | -93.0% | 500 | -90.9% | 0.00% | – |
| Q4 2015 | $43,000 | – | 5,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |